462 related articles for article (PubMed ID: 30828062)
21. Recanalization therapies for acute ischemic stroke.
Broderick JP
Semin Neurol; 1998; 18(4):471-84. PubMed ID: 9932618
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
[TBL] [Abstract][Full Text] [Related]
23. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
[TBL] [Abstract][Full Text] [Related]
24. Drug delivery to the ischemic brain.
Thompson BJ; Ronaldson PT
Adv Pharmacol; 2014; 71():165-202. PubMed ID: 25307217
[TBL] [Abstract][Full Text] [Related]
25. Brain Drug Delivery Systems for the Stroke Intervention and Recovery.
Luo T; Wang J; Hao S; Guo T; Ren P; Cheng Z; Gao F; Gong Y; Wang B
Curr Pharm Des; 2017; 23(15):2258-2267. PubMed ID: 27784243
[TBL] [Abstract][Full Text] [Related]
26. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
Candelario-Jalil E
Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
[TBL] [Abstract][Full Text] [Related]
27. The application of nanoparticles for neuroprotection in acute ischemic stroke.
Chen L; Gao X
Ther Deliv; 2017 Oct; 8(10):915-928. PubMed ID: 28944741
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective Effects of Radix Scrophulariae on Cerebral Ischemia and Reperfusion Injury via MAPK Pathways.
Meng X; Xie W; Xu Q; Liang T; Xu X; Sun G; Sun X
Molecules; 2018 Sep; 23(9):. PubMed ID: 30235876
[TBL] [Abstract][Full Text] [Related]
29. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice.
Wang HW; Liou KT; Wang YH; Lu CK; Lin YL; Lee IJ; Huang ST; Tsai YH; Cheng YC; Lin HJ; Shen YC
J Ethnopharmacol; 2011 Oct; 138(1):22-33. PubMed ID: 21784143
[TBL] [Abstract][Full Text] [Related]
31. Altered plasma and brain disposition of isopropylidene shikimic acid liposome in rats and the brain protection in cerebral ischemia-reperfusion.
Qu C; Ni J; Yang P; Zhang H; Lin L; Li J; Tian J; Fu J; Yin X; Kong H
Drug Dev Ind Pharm; 2013 Sep; 39(9):1291-5. PubMed ID: 23020069
[TBL] [Abstract][Full Text] [Related]
32. Liposomes for drug delivery in stroke.
Bruch GE; Fernandes LF; Bassi BLT; Alves MTR; Pereira IO; Frézard F; Massensini AR
Brain Res Bull; 2019 Oct; 152():246-256. PubMed ID: 31323280
[TBL] [Abstract][Full Text] [Related]
33. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotection in experimental stroke with targeted neurotrophins.
Wu D
NeuroRx; 2005 Jan; 2(1):120-8. PubMed ID: 15717063
[TBL] [Abstract][Full Text] [Related]
35. Hyperacute stroke therapy with tissue plasminogen activator.
Alberts MJ
Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of herbal drugs in cerebral ischemia.
Gupta YK; Briyal S; Gulati A
Indian J Physiol Pharmacol; 2010; 54(2):99-122. PubMed ID: 21090528
[TBL] [Abstract][Full Text] [Related]
37. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
[TBL] [Abstract][Full Text] [Related]
38. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
[TBL] [Abstract][Full Text] [Related]
39. Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats.
Campos-Martorell M; Cano-Sarabia M; Simats A; Hernández-Guillamon M; Rosell A; Maspoch D; Montaner J
Int J Nanomedicine; 2016; 11():3035-48. PubMed ID: 27418824
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.
Zamanlu M; Farhoudi M; Eskandani M; Mahmoudi J; Barar J; Rafi M; Omidi Y
J Drug Target; 2018 Feb; 26(2):95-109. PubMed ID: 28796540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]